Science Explorer Back to mapMap
Discussion
Topic · Immunology

T-cell and Retrovirus Studies

T-cell and Retrovirus Studies is a research topic within Immunology. Science Explorer counts 24k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the epidemiology, pathogenesis, clinical manifestations, treatment, and prevention of Human T-cell Leukemia Virus Type 1 (HTLV-1) infection. It covers topics such as viral transmission, proviral load, cellular transformation, immunotherapy, and the role of viral oncogenes in leukemia and lymphoma development.

  • HTLV-1
  • infection
  • leukemia
  • lymphoma
  • viral transmission
  • proviral load
  • cellular transformation
  • epidemiology
  • immunotherapy
  • viral oncogenes
Research works
24k
fractional, since 1950
In the world top 10%
2.5k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+8%
the tick is no change
Largest producer
United States
26% of the 10 largest, 2022-now
T-cell and Retrovirus Studies

Which countries lead T-cell and Retrovirus Studies research?

By volume, the United States and Brazil publish the most (486 and 436 works in 2022-now).

By volume, 2022-now

  1. 1 United States 486 works
  2. 2 Brazil 436 works
  3. 3 Japan 278 works
  4. 4 China 250 works
  5. 5 France 86 works
  6. 6 India 80 works
  7. 7 Iran 75 works
  8. 8 United Kingdom 67 works
  9. 9 Germany 56 works
  10. 10 Italy 51 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 26.0%Brazil: 23.4%Japan: 14.9%China: 13.4%6 others listed: 22.3%26%largest
United States486 · 26.0%Brazil436 · 23.4%Japan278 · 14.9%China250 · 13.4%6 others listed415 · 22.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead T-cell and Retrovirus Studies research?

By volume in 2022-now, Universidade de São Paulo publishes the most T-cell and Retrovirus Studies research, followed by The University of Tokyo and Albert Einstein College of Medicine.

By volume, 2022-now

  1. 1 Universidade de São PauloBrazil 30 works
  2. 2 The University of TokyoJapan 22 works
  3. 3 Albert Einstein College of MedicineUnited States 18 works
  4. 4 Kagoshima UniversityJapan 18 works
  5. 5 Universidade Federal do ParáBrazil 16 works
  6. 6 The University of Texas MD Anderson Cancer CenterUnited States 15 works
  7. 7 Mashhad University of Medical SciencesIran 14 works
  8. 8 Kumamoto UniversityJapan 13 works
  9. 9 National Institutes of HealthUnited States 13 works
  10. 10 Chinese Academy of Agricultural SciencesChina 13 works

Who are the leading researchers in T-cell and Retrovirus Studies?

The most-cited researchers publishing on T-cell and Retrovirus Studies include George Davey Smith, Guido Kroemer and Shizuo Akira.

  1. 1 George Davey Smith United Kingdom 435k citations
  2. 2 Guido Kroemer France 386k citations
  3. 3 Shizuo Akira Japan 342k citations
  4. 4 Matthias Egger Switzerland 326k citations
  5. 5 Naohiro Yonemoto Japan 297k citations
  6. 6 Todd R. Golub United States 283k citations
  7. 7 Michael Karin United States 276k citations
  8. 8 Hagop M. Kantarjian United States 273k citations
  9. 9 Gordon Brent Mills United States 265k citations
  10. 10 Charles M. Perou United States 263k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in T-cell and Retrovirus Studies?

The most cited paper in T-cell and Retrovirus Studies is "Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)" (Françoise Barré‐Sinoussi, Jean‐Claude Chermann, FA Rey et al., 1983), with 6,979 citations. Next come "Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma" (5,108) and "Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS" (3,658).

Most cited papers
#PaperReleasedCitations
1 Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS) Françoise Barré‐Sinoussi, Jean‐Claude Chermann, FA Rey et al. · Science 20 May 1983 6,979
2 Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma Bernard J. Poiesz, Francis W. Ruscetti, Adi F. Gazdar et al. · Proceedings of the National Academy of Sciences Open access Dec 1980 5,108
3 Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS Robert C. Gallo, Syed Zaki Salahuddin, Mikuláš Popovič et al. · Science 4 May 1984 3,658
4 Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS Mikuláš Popovič, M. G. Sarngadharan, Elizabeth J. Read et al. · Science 4 May 1984 3,556
5 The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus Angus George Dalgleish, Peter C. L. Beverley, Paul R. Clapham et al. · Nature 20 Dec 1984 3,548
All 100 most cited papers, with filters and sorting

Where is T-cell and Retrovirus Studies research done?

The largest centres of T-cell and Retrovirus Studies research in 2022-now are São Paulo (Brazil), Tokyo (Japan), Rio de Janeiro (Brazil) and Beijing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Kagoshima, Belém and Salvador.

Largest cities, 2022-now

  1. 1 São PauloBrazil 98 works
  2. 2 TokyoJapan 63 works
  3. 3 Rio de JaneiroBrazil 40 works
  4. 4 BeijingChina 37 works
  5. 5 New YorkUnited States 35 works
  6. 6 LondonUnited Kingdom 33 works
  7. 7 ParisFrance 33 works
  8. 8 BelémBrazil 32 works
  9. 9 TehranIran 27 works
  10. 10 SalvadorBrazil 25 works

Where it is the local speciality

  1. KagoshimaJP · 20.9 works63×
  2. BelémBR · 31.8 works18×
  3. SalvadorBR · 25.4 works15×
← less than its size predicts1×more →

Location quotient: how much more of its research is in T-cell and Retrovirus Studies than the world average.

See T-cell and Retrovirus Studies on the map

Where is the best place to study T-cell and Retrovirus Studies?

Among universities, judged by research, Imperial College London, Kumamoto University and The University of Tokyo score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 16.78%fractional works in this field (log) →share of work in the world top 10% →Imperial College Lon…Kumamoto UniversityThe University of To…Universidade de São …
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Imperial College LondonUnited Kingdom 70.134.0%5.4×12 -0.6%
2Kumamoto UniversityJapan 67.333.4%41.1×13 +54.9%
3The University of TokyoJapan 62.311.1%8.1×22 +66.8%
4Universidade de São PauloBrazil 57.15.2%6.8×30 +60.3%
5Harvard UniversityUnited States 55.818.2%1.7×12 +15.0%
6Kagoshima UniversityJapan 50.48.6%73.4×18 +38.3%
7Cornell UniversityUnited States 48.523.6%3.0×9 +40.6%
8The Ohio State UniversityUnited States 47.527.7%3.7×10 +23.7%
9Albert Einstein College of MedicineUnited States 46.10.7%24.5×18 +103.9%
10Universidade Federal do ParáBrazil 43.15.3%18.8×16 +14.8%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in T-cell and Retrovirus Studies, country by country

Is T-cell and Retrovirus Studies research growing?

Output in 2022-2025 was 8% higher than in 2018-2021, peaking in 2015. The fastest-growing topics are T-cell and Retrovirus Studies.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is T-cell and Retrovirus Studies as a percentage of every work published that year, 0.011% in 2024.

still counting0.050%0.10%T-cell and Retrovirus Studies0.010% in 202519801990200020102020

Fractional works of T-cell and Retrovirus Studies over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%T-cell and Retrovirus Studies10.6% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about T-cell and Retrovirus Studies. Posts are plain text and can be reported.